Publication | Closed Access

A phase I dose-escalation clinical trial of intraoperative direct intratumoral injection of HF10 oncolytic virus in non-resectable patients with advanced pancreatic cancer

Surgical OncologyPancreatic CancerMedicineImmunologyHf10 Oncolytic VirusPancreatic SurgeryAdvanced Pancreatic CancerCancer TreatmentOncologyRadiation Oncology